GH Research PLC Files 6-K with Financial Updates

Ticker: GHRS · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1855129

Sentiment: neutral

Topics: financial-reporting, balance-sheet, sec-filing

TL;DR

GH Research PLC dropped its Q2 2024 financials in a 6-K filing, showing balance sheet details.

AI Summary

GH Research PLC filed a 6-K report on September 3, 2024, detailing financial information for the period ending June 30, 2024. The filing includes balance sheet items such as Additional Paid-in Capital, Retained Earnings, Issued Capital, and Reserves for Exchange Differences on Translation for the fiscal years ending December 31, 2022, and December 31, 2023, as well as interim periods within 2023 and 2024.

Why It Matters

This filing provides investors with an update on GH Research PLC's financial position, including key balance sheet components, which is crucial for assessing the company's financial health and performance.

Risk Assessment

Risk Level: low — This is a routine financial filing (6-K) that provides updated balance sheet information and does not appear to contain significant new risks or material events.

Key Numbers

Key Players & Entities

FAQ

What specific financial statements are detailed in this 6-K filing?

The filing details balance sheet information, including components like Additional Paid-in Capital, Retained Earnings, Issued Capital, and Reserves for Exchange Differences on Translation.

For which periods does GH Research PLC provide financial data in this filing?

The filing provides data for the period ending June 30, 2024, and comparative data for the fiscal years ending December 31, 2023, and December 31, 2022, as well as interim periods within 2023 and 2024.

What is the Central Index Key (CIK) for GH Research PLC?

The Central Index Key for GH Research PLC is 0001855129.

When was this 6-K filing submitted to the SEC?

This 6-K filing was submitted on September 3, 2024.

What is the primary business of GH Research PLC according to the filing?

GH Research PLC is classified under Pharmaceutical Preparations (SIC code 2834).

Filing Stats: 418 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2024-09-03 07:21:19

Filing Documents

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 99.3 Press release dated September 3, 2024 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: September 3, 2024 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing